Cerenis Therapeutics has Decided to Terminate the Proposed Merger with H4Orphan Pharma

TOULOUSE, France–(BUSINESS WIRE)–Regulatory News: Cerenis Therapeutics (FR0012616852 – CEREN – PEA PME eligible), an international biopharmaceutical company dedicated to the discovery and development of HDL-based innovative therapies for treating cardiovascular and metabolic diseases, as well as new HDL-based vectors for targeted drug delivery in the field of oncology, announces that the […]


ABBOTT PARK, Ill., April 17, 2019 /PRNewswire/ — Abbott (NYSE: ABT) today announced financial results for the first quarter ended March 31, 2019. First-quarter worldwide sales of $7.5 billion increased 2.0 percent on a reported basis and 7.1 percent on an organic* basis. Reported diluted EPS from continuing operations under GAAP was $0.38 in the first quarter. […]

Bardy Diagnostics™ Announces $35.5M in Series B Funding Round

SEATTLE, April 16, 2019 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced today it has raised $35.5 million in Series B funding, led by River Cities Capital Funds with participation from new investors HealthQuest Capital, Aperture Venture Partners, Aphelion Capital, Lumira Ventures, and Rex Health Ventures. Existing […]

Endologix, Inc. to Announce First Quarter 2019 Financial Results on May 2, 2019

IRVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that it will report financial results for the first quarter of fiscal year 2019 after the market close on Thursday, May 2, 2019. The Company’s management will host a conference call at 4:30 p.m. […]

Proteon Therapeutics Announces Review of Potential Strategic Transactions

WALTHAM, Mass., April 15, 2019 (GLOBE NEWSWIRE) — Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with kidney and vascular diseases, today announced its plans to explore a range of strategic options to enhance shareholder value. Having missed statistical significance on both […]

Johnson & Johnson Reports 2019 First-Quarter Results:

NEW BRUNSWICK, N.J., April 16, 2019 /PRNewswire/ — Johnson & Johnson (NYSE: JNJ) today announced results for first-quarter 2019. “Our strong first-quarter results reflect continued underlying operational sales and adjusted EPS growth,” said Alex Gorsky, Chairman and Chief Executive Officer. “At the same time, we remain focused on investing in innovative technologies and platforms that […]

Milestone Pharmaceuticals Appoints Paul Edick Chairman of its Board of Directors

MONTREAL and CHARLOTTE, N.C., April 16, 2019 /PRNewswire/ — Milestone Pharmaceuticals, a late-stage biopharmaceutical company developing acute therapies for the treatment of episodic cardiovascular conditions, today announced the appointment of Paul Edick as Chairman of its Board of Directors. Mr. Edick currently serves as Chairman and Chief Executive Officer of Xeris Pharmaceuticals, a publicly traded specialty pharmaceutical company […]

Robbins Arroyo LLP Is Investigating the Officers and Directors of iRhythm Technologies, Inc. (IRTC) on Behalf of Shareholders

SAN DIEGO & SAN FRANCISCO–(BUSINESS WIRE)–Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of iRhythm Technologies, Inc. (NASDAQ: IRTC) breached their fiduciary duties to shareholders by failing to maintain effective internal controls over financial reporting. iRhythm is a digital healthcare company that provides ambulatory electrocardiogram monitoring […]

Catasys Appoints Healthcare Industry Leader Carol Murdock to Newly Created Chief Commercial Officer Role

LOS ANGELES–(BUSINESS WIRE)–Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced the appointment of Carol Murdock as Chief Commercial Officer. She will lead Business Development, Account Management, Marketing and Corporate Communications, reporting to Mr. Terren Peizer, Chairman and CEO. Ms. Murdock joins the […]

Silk Road Medical Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

SUNNYVALE, Calif., April 08, 2019 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK) (“Silk Road Medical”), a company focused on reducing the risk of stroke and its devastating impact, today announced the closing of its initial public offering of 6,000,000 shares of common stock, and the exercise in full of the […]